RenovoRx held its annual meeting on June 30, 2026. Shareholders elected six directors to one-year terms: Shaun R. Bagai, Ramtin Agah, Kirsten Angela Macfarlane, Laurence J. Marton, Una S. Ryan, and Robert J. Spiegel. They also approved an amendment to the company's 2021 Omnibus Equity Incentive Plan and ratified the appointment of Frank, Rimerman + Co. LLP as independent auditor for the fiscal year ending December 31, 2026.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding RENOVORX INC (RNXT)?

Major stakeholders currently include AIGH Capital Management LLC ($3.7M), Bleichroeder LP ($1.7M), Vanguard Capital Management LLC ($1.5M). Based on the latest 13F filings, there are a total of 31 tracked investment funds and institutions maintaining positions in RNXT.

What is the overall institutional sentiment toward RNXT recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $1.8M, driven by 13 managers accumulating shares while 9 reduced their exposure.

Which institutions have been selling or reducing their RNXT positions?

In the latest period, 4 funds trimmed their holdings, and 5 managers completely exited their positions. The aggregate reported sell value was $261.4K.

Are there any notable investors adding RNXT to their portfolios?

Yes, buying activity remains notable. 2 institutions opened new positions in {ticker}, and 11 existing holders added to their shares. The total reported buy value for the quarter amounted to $6.2M.